Anticoagulations and Coagulants

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Hemostasis, Surgical Bleeding, and Transfusion
Drugs for Coagulation Disorders
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
ANAESTHESIA AND ANTICOAGULANTS
Thromboembolic Disorders and Related Medications Nsg 106 Pharmacotherapeutics.
Vascular Pharmacology
PTP 546 Module 6 Cardiovascular Pharmacology: Part II Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
Anticoagulants and Thrombolytic
Coagulation Modifier Drugs
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Interactive Session on Clotting Profile Dr P T R Makuloluwa MBBS (Col), MD (Anaesthesiology), FRCA (Lond)
Drugs for Management of Fever & Inflammation
Hemostasis and Blood Coagulation
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Coagulation Modifier Drugs.
ANTICOAGULANT BY :DR ISRAA OMAR.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
BY :DR. ISRAA OMAR.  It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin,which digest fibrin.  The.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Anticoagulants and Narcotics. Prevent coagulation of thrombocytes (platelets) Side effects: bleeding, hematuria, black feces Some are photosensistive.
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
Thrombolytic drugs BY :DR. ISRAA OMAR.
Hemostasis. Defined Stopping or arresting the loss of blood or hemorrhage.
BY :DR. ISRAA OMAR.  It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin,which digest fibrin.  The.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
ANTICOAGULANT BY :DR ISRAA OMAR. Definition of Anticoagulation Therapeutic interference ("blood-thinning") with the clotting mechanism of the blood to.
Valvular Heart Disease NR40. Valvular Heart Disease Stenosis Regurgitation (Insufficiency) Prolapse.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 27 Coagulation Modifier Drugs.
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Fibrinolytics, anticoagulants and antiplatelets
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Chapter 9 Medications that Affect Coagulation Elsevier items and derived items © 2006 by Saunders, an imprint of Elsevier Inc.
Blood coagulation is a complex process that involves vasoconstriction, platelet clumping or aggregation, and a cascade of clotting factors produced in.
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Agents Affecting Blood Clotting
At the end of session students should be able to:  Know the normal hemostatic pathway  Know Parenteral anticoagulant drugs  Know pharmacokinetics,
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
Anticoagulants, Antiplatelets, and Thrombolytics
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Drugs Used in Coagulation Disorders Presented by Dr. Sasan Zaeri PharmD, PhD.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
Drugs Used in Coagulation Disorders
23 Anticoagulants.
Blood/Blood Formation
Anticoagulants, Antiplatelets, and Thrombolytics
These factors prevent blood clotting - in normal state.
Anticoagulants and Antiplatelets
The normal haemostasis process involves three stages: 1
and anti-thrombotic pharmocology Tom Williams
Coagulation Modifier Drugs
Coagulation Disorders
Module 3 REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY.
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Anticoagulant Reversal
23 Anticoagulants.
ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB.
Anticoagulants.
Presentation transcript:

Anticoagulations and Coagulants NUR 312 Brenda B. Rowe

Anticoagulants Prevent thrombus formation and the extension of existing thrombus Heparin: onset 20-60 minutes, given via continuous infusion or subc., most common side effect is bleeding, antidote is protamine sulfate, want therapeutic lengthening of clotting time, monitor APTT - should be 1.5-2 x control

enoxaparin (Lovenox Considered safer and equally effective as heparin used for prophylaxis given subcutaneous patient teaching

Coumadin Oral anticoagulant anticoagulant. Effects do not begin for 24 hours with maximum effect in 3-4 days, pt. will receive coumadin before heparin is d/c increase change of bleeding with aspirin, NSAIDS, & chronic use of Tylenol Education: avoid diets high in Vitamin K, take at same time, check out OTC drugs

Coumadin (cont.) PT (prothrombin time) or INR (international normalized ratio) monitor therapeutic results with these lab tests (I.e. PT 1.4-1.6 x control, INR should be 2-3) Antidote is vitamin K

Ticlid Inhibits platelet aggregation used with patients who cannot tolerate aspirin most common side effect is diarrhea should not be administered with aspirin should be given with food monitor neutrophils & platelet count

aspirin Antiplatelet Prophylaxis – MI & TIA

streptokinase Breaks down formed clot most effective if initiated within 6 hours of onset of symptoms severe bleeding occurs frequently & fever occurs in 30% of patients

Clotting factors & hemostatics antihemophilic factor (AHF) - used to treat patients with deficiency of clotting factor VIII, hemophilia A human factor IX complex: tx hemophilia B aminocaporic acid: enhances blood coagulation/used to tx severe bleeding

Topical hemostatic agents oxidized cellulose (Surgicel) gelatin (Gelfoam)